TRENDING:

The End of PDMP Information Overload: Welcome to Target...
Miami “Patient Recruiter” Pleads Guilty in ...
A Kratom-Derived Opioid, a Mislabeled Package, and a Bl...
DOJ’s Los Angeles Takedown Puts Data Analytics an...
PDMPNews
  • Home
  • News
    • PDMP
    • Intelligence
    • Research
    • AI
    • Enforcement
  • About
  • Contact

Select Page

The End of PDMP Information Overload: Welcome to Targeted Intelligence

The End of PDMP Information Overload: Welcome to Targeted Intelligence

Posted by Editor | Sep 21, 2025 | Intelligence, PDMP |

PDMP News is transitioning from aggregated healthcare news to curated, actionable content...

Read More
A Kratom-Derived Opioid, a Mislabeled Package, and a Blind Spot for PDMPs

A Kratom-Derived Opioid, a Mislabeled Package, and a Blind Spot for PDMPs

Posted by PDMPNews Staff | Oct 23, 2026 | Drugs, PDMP, Policy |

A San Francisco death linked to MGM-15, found in a product sold as “cat’s claw,” shows how a fast-changing, mislabeled opioid market sits entirely outside prescription monitoring.

Read More
DOJ’s Los Angeles Takedown Puts Data Analytics and Addiction-Treatment Integrity in Focus

DOJ’s Los Angeles Takedown Puts Data Analytics and Addiction-Treatment Integrity in Focus

Posted by PDMPNews Staff | Oct 23, 2026 | Enforcement, PDMP |

The Justice Department’s October 22 announcement pairs what DOJ calls its largest sober-home fraud case with cases flagged by billing analytics, a combination that speaks directly to how treatment integrity is policed.

Read More
Medetomidine Withdrawal: Two New Studies Sharpen a Growing Clinical Concern

Medetomidine Withdrawal: Two New Studies Sharpen a Growing Clinical Concern

Posted by PDMPNews Staff | Oct 23, 2026 | Drugs, PDMP, Research |

As the veterinary sedative medetomidine displaces xylazine in Philadelphia and parts of the Northeast and Midwest, a single case report and a transport study add detail to a withdrawal syndrome that can require intensive care.

Read More

DEA Revokes Pennsylvania Psychiatrist’s Registration, With the State PDMP on Both Sides of the Case

Posted by PDMPNews Staff | Oct 20, 2026 | Enforcement |

On October 19, 2026, the Drug Enforcement Administration published a Decision and Order revoking the DEA registration of Muhamad Aly Rifai, M.D., a psychiatrist registered in Easton, Pennsylvania (91 FR 66156, FR Doc....

Read More
PDMP Mandates Trimmed Buprenorphine Shipments to Pharmacies, but Mandates Plus EHR Integration Lifted Methadone Supply

PDMP Mandates Trimmed Buprenorphine Shipments to Pharmacies, but Mandates Plus EHR Integration Lifted Methadone Supply

Posted by PDMPNews Staff | Oct 17, 2026 | PDMP, Policy, Research |

University of Iowa researchers looked at 13 years of state PDMP policy and found that mandatory...

Read More
After Victoria Mandated Its PDMP, Only Half of Surveyed Pharmacists Said They Checked It Every Time

After Victoria Mandated Its PDMP, Only Half of Surveyed Pharmacists Said They Checked It Every Time

Posted by PDMPNews Staff | Oct 17, 2026 | PDMP, Research |

A Monash University survey of community pharmacists in Victoria, Australia, found that the share...

Read More
Nearly a Third of Telemedicine Buprenorphine Patients Went Without Medication Because of Pharmacy Barriers

Nearly a Third of Telemedicine Buprenorphine Patients Went Without Medication Because of Pharmacy Barriers

Posted by PDMPNews Staff | Oct 17, 2026 | PDMP, Policy, Research |

A survey of 601 adults treated for opioid use disorder by telemedicine in five states found that...

Read More
CDC: Stimulants Were Involved in 59% of U.S. Overdose Deaths From 2021 to Mid-2024, Mostly Alongside Opioids

CDC: Stimulants Were Involved in 59% of U.S. Overdose Deaths From 2021 to Mid-2024, Mostly Alongside Opioids

Posted by PDMPNews Staff | Oct 17, 2026 | Intelligence, Research |

A CDC analysis of more than 309,000 overdose deaths found that stimulants, mainly methamphetamine...

Read More
People Treated With Addiction Medication in Massachusetts Jails Had Lower Overdose Death Risk After Release

People Treated With Addiction Medication in Massachusetts Jails Had Lower Overdose Death Risk After Release

Posted by PDMPNews Staff | Oct 17, 2026 | PDMP, Policy, Research |

People with opioid use disorder who received medication while held in seven Massachusetts county...

Read More
DEA Resets Its Kratom-Derivative Scheduling Plan Around a New HHS Threshold

DEA Resets Its Kratom-Derivative Scheduling Plan Around a New HHS Threshold

Posted by Don Vogt | Oct 16, 2026 | Policy |

DEA has withdrawn its July plan for 7-hydroxymitragynine and now intends to temporarily place both...

Read More
  • 1
  • 2
  • 3

Recent Posts

  • A Kratom-Derived Opioid, a Mislabeled Package, and a Blind Spot for PDMPs
  • DOJ’s Los Angeles Takedown Puts Data Analytics and Addiction-Treatment Integrity in Focus
  • Medetomidine Withdrawal: Two New Studies Sharpen a Growing Clinical Concern
  • DEA Revokes Pennsylvania Psychiatrist’s Registration, With the State PDMP on Both Sides of the Case
  • PDMP Mandates Trimmed Buprenorphine Shipments to Pharmacies, but Mandates Plus EHR Integration Lifted Methadone Supply

© 2026 PDMPNews · About · Privacy Policy · Contact · A OnePMP publication